Polynucleotides encoding a multiple epitope fusion antigen...

Details Polynucleotides encoding a multiple epitope fusion antigen... Polynucleotides encoding a multiple epitope fusion antigen...

2008-01-15

2008-01-15

Lucas, Zachariah (Department: 1648)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C536S023400, C435S069100, C435S069300, C435S069700, C435S320100, C424S184100, C424S186100, C424S189100, C424S192100, C424S228100

Reexamination Certificate

active

10643853

ABSTRACT:
The invention relates to a method of detecting HCV infection in a biological sample, the method comprising providing an immunoassay solid support, comprising an HCV anti-core antibody, an antigen comprising an HCV NS3/4aepitope, and an HCV multiple epitope fusion antigen, that can detect both HCV antigens and antibodies present in a sample. The invention also includes polynucleotides encoding multiple epitope fusion antigens for use in the assay, recombinant vectors and host cells comprising such polynucleotides, and methods of producing the multiple epitope fusion antigens.

REFERENCES:
patent: 5350671 (1994-09-01), Houghton et al.
patent: 5683864 (1997-11-01), Choo et al.
patent: 5712087 (1998-01-01), Houghton et al.
patent: 5843752 (1998-12-01), Dasmahapatra et al.
patent: 5871904 (1999-02-01), Kashiwkuma et al.
patent: 5990276 (1999-11-01), Zhang et al.
patent: 6001604 (1999-12-01), Hartman et al.
patent: 6171782 (2001-01-01), Houghton et al.
patent: 0 318 216 (1989-05-01), None
patent: 0 388 231 (1990-09-01), None
patent: 0 388 232 (1990-09-01), None
patent: 0 450 931 (1991-10-01), None
patent: 0 472 207 (1992-02-01), None
patent: WO93/00365 (1993-01-01), None
patent: WO97/44469 (1993-11-01), None
patent: WO94/01778 (1994-01-01), None
patent: WO94/25601 (1994-11-01), None
Puntoriero et al., “Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants” EMBO Journal, vol. 17 No. 13, pp. 3521-3533 (Jul. 1998).
Bowie et al., “Deciphering the message in protein sequences: tolerance to amino acid substitutions,” Science, vol. 247 No. 4948, pp. 1306-1310 (Mar. 1990).
Riffkin et al., “A single amino-acid change between the antigenically different extracellular serine proteases V2 and B2 fromDichelobacter nodosus,” Gene, vol. 167 Nos. 1-2, pp. 279-283 (Dec. 1995).
Watanabe et al., “The Hypervariable Region 1 Protein of Hepatitis C Virus Broadly Reactive with Sera of Patients with Chronic Hepatitis C Has a Similar Amino Acid Sequence with the Consensus Sequence,” Virology, vol. 264 No. 1, pp. 153-158 (Nov. 1999).
Beld et al., “Evaluation of Automated RNA-Extraction Technology and a Qualitative HCV Assay for Sensitivity and Detection of HCV RNA in Pool-Screening Systems,”Transfusion 40:575-579 (2000).
Chen et al., “Human and murine antibody recognition is focused on the ATPase/helicase domain, but not the protease domain to the hepatitis C virus non-structural 3 protein,”Hepatology28:219-224, 1998.
Chien et al., “Diagnosis of Hepatitis C virus (HCV) Infection Using an Immunodominant Chimeric Polyprotein to Capture Circulating Antibodies: Revaluation of the Role of HCV in Liver Disease,”Proc. Natl. Acad. Sci. U.S.A. 89:10011-10015 (1992).
Chien et al., “Use of Recombiant HCV Antigen in the Serodiagnosis of Hepatits C virus Infection: significant Improvement in HCV Antibody Detection as Compared With eht First Generation HCV C100-3 ELISA and the Synthetic Peptide EIA Tests,”Journal of Gastroenterology and Hepatology 8:S33-39 (1993).
Chien et al., “Distinct Subtypes of Hepatitis C Virus Defined by Antibodies Directed to the Putative Core, NS4, and NS5 Region Polypeptides,”Virol. Hepatitis and Liver Disease320-324 (1994).
Choo et al., “Isolation of a cDNA Clone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome,”Science 244:359-362 (1989).
Choo et al., “Hepatitis C Virus: The Major Causative Agent of Viral Non-A, Non-B Hepatitis,”British Medical Bulletin 46:423-441 (1990).
Cruse et al., Illustrated Dictionary of Immunology, CRC Press, Boca Raton FL, 1995, p. 76.
Ebeling et al., “Recombinant Immunoblot Assay for Hepatitis C Virus Antibody as Predictor of Infectivity,”Lancet 335:982-983 (1990).
Houghton et al., “Molecular Biology of the Hepatitis C Viruses: Implications for Diagnosis, Development and Control of Viral Diesease,”Hepatology 14:381-388 (1991).
Kotwal et al., “Detection of Acute Hepatitis C Virus Infection by ELISA Using a Synthetic Peptide Comprising a Structural Epitope,”Proc. Natl. Acad. Sci. U.S.A. 89:4486-4489 (1992).
Kuo et al., “An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non B Hepatitis,”Science 244:362-364 (1989).
Pereboeva et al., “Hepatitis C epitopes from phage-displayed cDNA libraries and improved diagnosis with a chimeric antigen,” J. Medical Virology 60:144-151, 2000.
van der Poel et al., “Infectivity oif Blood Seropositive for Hepatitis C Virus Antibodies,”Lancet 335:558-560 (1990).
van der Poel et al., “Confirmation of Hepatitis C Virus Infection by New Four-Antigen Recombinant Immunoblot Assay,”Lancet 337:317-319 (1991).
Yao et al., “Molecular Views of Viral Polyprotein Processing Revealed by the Crystal Structure of the Hepatitis C Virus Bifunctional Protease-Helicase,”Structure 7(11):1353-1363 (1999).
Chien et al., “Use of a Novel Hepatitis C Virus (HCV) Major-Epitope Chimeric Polypeptide for Diagnosis of HCV Infection,” Journal of Clinical Microbiology, Washington, DC, US, 37(5):1393-1397 (1999).
Kashiwakuma et al., “Detection of Hepatitis C Virus Specific Core Protein in Serum of Patients by a Sensitive Fluorescence Enzyme Immunoassay (FEIA),” Journal of Immunological Methods, Elsevier Science Publishers B.V., Amsterdam, NL, 190(1):79-89 (1996).
Ning Yang et al., “Examination of IGM Antibody to Hepatitis C and Analysis on Hepatitis C Patients' Sera,” Zhonghua Weishengwuxue He Mianyixue Zazhi, 15(4):254-257 (1995) XP001121826.
Qi Zibai et al., “Evaluation of the Capabilities for Detecting Anti-HCV Core and NS3 Antibodies with Two Anti-HGV EIA Kits of the Third Generation,” Zhonghua Weishengwuxue He Mianyixue Zazhi, 19(5):433-435 (1999) XP001121825.

Affiliated with

Also associated with

Rating

Polynucleotides encoding a multiple epitope fusion antigen... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polynucleotides encoding a multiple epitope fusion antigen..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polynucleotides encoding a multiple epitope fusion antigen... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3929724